WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 452
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 572

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 7'619  7'464  7'309  7'155  7'001  5'374  4'158  3'215 
Births 215  213  211  210  208  187  146  127 
Surviving infants 205  203  201  200  198  176  136  117 
Pop. less than 5 years 996  989  985  980  972  835  635  556 
Pop. less than 15 years 2'830  2'802  2'773  2'743  2'708  2'160  1'756  1'456 
Female 15-49 years 1'917  1'870  1'822  1'776  1'731  1'324  988  712 

Number of reported cases

(Click for retrospective incidence data for Papua New Guinea)
Diphtheria
ChartChart
  15 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  38  2'299  12  7'135  4'575  12'125 
Mumps
ChartChart
 
Pertussis
ChartChart
  3'188  6'472  4'625  2'280  2'084  2'693 
Polio*
ChartChart
  22 
Rubella
ChartChart
  84  33  19 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  27  32  56  138 
Tetanus (total)**
ChartChart
  27  32  56  138  115  68 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Papua New Guinea)
Vaccine year result method % card seen                                                
BCG 2004  90     93  65  81  88  84  83  81  92  62 
DTP1 2004  88     93  83  87  88  85  83  84  97 
DTP3 2004  71     93  62  62  68  63  61  59  68  32 
DTP4         
IPV1         
HepB_BD          32  31  37  35  31  24 
HepB3 2004  73     93  62  62  68  63  61  57  20 
Hib3          62  62  68  63  61 
JapEnc         
MCV1          60  65  70  67  60  62  66 
MCV2          53 
PCV1          24 
PCV3          20 
Pol3 2004  69     93  63  53  69  70  58  47  68  29 
Rota1         
RotaC         
Rubella1         
TT2plus          50  50  67  59  51  10  81  50 
PAB         
VAD1          69  57  52  18 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Papua New Guinea)
BCG
ChartChart
  65  81  88  84  83  81  92  62 
DTP1
ChartChart
  83  87  88  85  83  84  97  57 
DTP3
ChartChart
  62  62  68  63  61  59  68  32 
HepB3
ChartChart
  62  62  68  63  61  57 
HepB_BD
ChartChart
  32  31  37  35  31 
Hib3
ChartChart
  62  62  68  63  61 
IPV1
ChartChart
 
MCV1
ChartChart
  60  65  70  67  60  62  67 
MCV2
ChartChart
 
PAB
ChartChart
  70  70  65  70  61  24  78  45 
PCV3
ChartChart
  20 
Pol3
ChartChart
  63  53  69  70  58  47  68  29 
RCV1
ChartChart
 
RotaC
ChartChart
 

Number of districts in the country 89  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
83 
   
/
|
|
\
Greater or equal to 90% 12
From 80 to 89% 8
From 50 to 79% 31
Less than 50% 48
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 1, 2, 3 months; Yes
HepB birth; Yes
IPV 3 months; Yes
MR 6, 9, 18 months; Yes
OPV 1, 2, 3 months; Yes
Pneumo_conj 1, 2, 3 months; Yes
TT 7, 13 years; Yes
VitaminA 6, 12, 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2011-2015  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 89  89  89  89  80  89  89 

System performance

Total Nº districts in country number 89  89  89  89  89  89  89 
Nº districts with DTP3 coverage >=80% number 18  28  35  30  20  30  11 
% of districts with DTP3 coverage >=80% From 0 to 100% 20  31  39  34  22  34  12 
Nº districts with measles (MCV1) coverage >=95% number 12  23  27  19 
% of districts with MCV1 coverage >=95% From 0 to 100% 13  26  30  21 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 54  25  40  80  75  70  50 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.